CTCL
Clinical trials for CTCL explained in plain language.
Never miss a new study
Get alerted when new CTCL trials appear
Sign up with your email to follow new studies for CTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat skin cancer: PTX-100 trial launches
Disease control Recruiting nowThis study tests a new drug called PTX-100 in people with a rare type of skin lymphoma (CTCL) that has come back or not responded to other treatments. About 115 adults will receive the drug by IV over several cycles to see if it shrinks tumors and is safe. The goal is to control …
Matched conditions: CTCL
Phase: PHASE2 • Sponsor: Prescient Therapeutics, Ltd. • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Light-Activated gel shows promise in fighting rare skin cancer
Disease control Recruiting nowThis study tests a gel called HyBryte that, when activated by light, targets cancer cells in the skin. It is for people with early-stage cutaneous T-cell lymphoma (a rare type of skin lymphoma). About 80 participants will apply the gel to their skin lesions and then receive a spe…
Matched conditions: CTCL
Phase: PHASE3 • Sponsor: Soligenix • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
New gel could offer relief from Cancer-Related skin itching without heavy steroid use
Symptom relief Recruiting nowThis study tests if a special gel called StrataCTX can help reduce itching and the need for steroid creams in people with skin reactions from cutaneous T-cell lymphoma (CTCL) or chemotherapy/immunotherapy. About 70 adults will use the gel alongside their usual steroid treatment. …
Matched conditions: CTCL
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC